Paul LePage: SPECIFIC ILLNESSES

Allergies

In 2015, Bipartisan Majorities in the House and Senate Overrode LePage’s Veto of a Bill Allowing Entities Where Allergens Capable of Causing an Allergic Shock Might be Present to Stock Epi-Pens and Administer Them to People Believed to be in Anaphylactic Shock. In June 2015, the House overrode LePage’s veto of LD1125 by a 143-4 vote and the Senate by a 26-9 vote. LD1125 “allows entities, organizations and places of employment at which allergens capable of causing anaphylaxis may be present, other than schools, to stock prescribed epinephrine autoinjectors and administer them to persons believed in good faith to be experiencing anaphylaxis and provides that those entities, organizations and places of employment may not be held liable for any injuries or related damages that may result. It requires training for employees or agents of such entities, organizations or places of employment.” [Summaries of Bills, LD1125, 2015; Maine State Legislature, LD1125, 2015]

Colon Cancer

LePage Lost $1 Million in Federal Funding for Colorectal Cancer Screenings for Low-Income People, Despite Colon Cancer Being the Third Leading Cause of Cancer Death in Maine:

Image: see original report, p. 278

Image: see original report, p. 279

[Maine Center for Economic Policy, 3/21/17]

Lyme Disease

In 2015, LePage Refused to Sign Bipartisan Legislation Allowing Licensed Physicians to Prescribe, Administer, and Dispense Long-Term Antibiotic Therapy for Patients with Lyme Disease. In June 2015, LePage allowed LD422 to become law without his signature after it passed the House by a 106-34 vote and the Senate without a roll call. LD422 “provides that a licensed physician may prescribe, administer or dispense long-term antibiotic therapy for a therapeutic purpose to eliminate infection or to control a patient's symptoms upon making a clinical diagnosis that the patient has Lyme disease or displays symptoms consistent with a clinical diagnosis of Lyme disease. It requires the clinical diagnosis and treatment to be documented in the patient's medical record by the prescribing licensed physician.” [Summaries of Bills, LD422, 2015; Maine State Legislature, LD422, 2015]

Source report (PDF)